Hyperreninic Arterial Hypertension — Difficulties in Differential Diagnosis. Clinical Observation

Secondary arterial hypertension (SAH) is characterised by the presence of a specific potentially treatable cause of hypertension, higher blood pressure (BP) values, often refractory to hypotensive therapy, and higher prevalence in young adults. Diagnosis of VtAH involves searching for causes according to the principle ‘from simple to complex’ at the outpatient and inpatient stages of examination. The article describes a clinical case of a 44-year-old woman without risk factors for AH, hospitalised for hypertensive crisis on the background of uncontrolled AH. Multistage laboratory and instrumental diagnostics was performed to exclude renal, endocrine, vascular pathology. High values of renin with normal values of other hormones of adrenal, pituitary, thyroid and parathyroid glands were the basis for searching for renal and extrarenal renin-producing tumours, which resulted in the diagnosis of hyperrenin essential AH. The article presents the classification of VtAH with a list of recommended diagnostic measures, principles of therapy of hyperreninic AH, which are of practical importance for the therapist, general practitioner, endocrinologist, nephrologist.

1. Chazova I.E., Chikhladze N.M., Blinova N.V., et al. Eurasian Clinical Guidelines for the Diagnosis and Treatment of Secondary (Symptomatic) Forms of Arterial Hypertension (2022). Eurasian Journal of Cardiology 2023;(1):6-65. [Electronic resource]. URL: https://doi.org/10.38109/2225-1685-2023-1-6-65 (date of the application: 15.04.2024) [In Russian]

2. Viera A.J., Neutze D.M. Diagnosis of secondary hypertension: an agebased approach. Am Fam Physician. 2010;82(12):1471-1478 Barentsz JO, Richenberg J, et. al. ESUR prostate MR guidelines 2012. Eur Radiol. 2012;22(4):746-757 DOI: 1532-0650.

3. Börgel J, Springer S, Ghafoor J, et al. Unrecognized secondary causes of hypertension in patients with hypertensive urgency/emergency: prevalence and co-prevalence. Clin Res Cardiol. 2010;99(8):499-506.

4. Troshina E.A., Beltsevich D.G., Yukina M.Yu. Laboratory Diagnostics of Pheochromocytoma. Problems of Endocrinology. 2010;56(4):39-43.

5. Trnka P, Orellana L, Walsh M, Pool L, Borzi P. Reninoma: an uncommon cause of Renin-mediated hypertension. Front Pediatr. 2014 Aug 15;2:89.PMID: 25177679; PMCID: PMC4133731.DOI: 10.3389/fped.2014.00089.

6. Kuroda N, Maris S, Monzon FA, Tan PH, Thomas A, Petersson FB, et al. Juxtaglomerular cell tumor: a morphological, immunohistochemical and genetic study of six cases. Hum Pathol(2013) 44(1):47–54 10.1016/j.humpath.2012.04.006. DOI: 10.1016/j.humpath.2012.04.006.

7. A.V. Barsukov, N.N. Korneichuk, and S.B. Shustov. High-Renin Arterial Hypertensions: From Symptoms to Diagnosis // Bulletin of the North-Western State Medical University named after I.I. Mechnikov. — 2017. — Vol. 9. — No. 2. — Pp. 7-18. DOI: 10.17816/mechnikov2017927-18. [In Russian].

8. Wong L, Hsu TH, Perlroth MG, Hofmann LV, Haynes CM, Katznelson L. Reninoma: case report and literature review. J Hypertens (2008) 26(2):368–73. DOI: 10.1097/HJH.0b013e3282f283f3.

9. Annabelle G Hayes, Michael Stowasser, Mahesh M Umapathysivam, Henrik Falhammar, David J Torpy, Approach to the Patient: Reninoma, The Journal of Clinical Endocrinology & Metabolism, Volume 109, Issue 2, February 2024, Pages e809–e816. DOI: 10.1210/clinem/dgad516.

10. Hepburn S, Munday C, Taylor K, Halsall DJ. Stability of direct renin concentration and plasma renin activity in EDTA whole blood and plasma at ambient and refrigerated temperatures from 0 to 72 hours. Clin Chem Lab Med. 2022;60(9):1384-1392. DOI: 10.1515/cclm-2022-0375.

11. Jiang S, Yang Y, Wu R, et al. Characterization and management of juxtaglomerular cell tumor: analysis of 9 cases and literature review. Balkan Med J. 2020;37(5):287-290. DOI: 0.4274/balkanmedj.galenos.2020.2019.12.79.